article thumbnail

Vermont: Legislation Becomes Law Increasing THC Limits, Plant Counts for Patients

NORML

The new law significantly increases the amount of cannabis patients may home cultivate and doubles the amount of THC available in certain marijuana products. The post Vermont: Legislation Becomes Law Increasing THC Limits, Plant Counts for Patients appeared first on NORML.

Patients 218
article thumbnail

THC versus Breast Cancer

Project CBD

It’s no secret that many cancer patients are using cannabis to help manage pain, fatigue, nausea, and other side effects of chemotherapy.

THC 279
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Georgia: Regulators Finally License Retailers to Begin Selling Low-THC Cannabis Products to Authorized Patients

NORML

"For almost ten years, patients and their providers have lacked the ability to locally access these medically necessary state-approved products from state-licensed retailers. The post Georgia: Regulators Finally License Retailers to Begin Selling Low-THC Cannabis Products to Authorized Patients appeared first on NORML.

Retail 203
article thumbnail

Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects

NORML

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.

article thumbnail

Dronabinol: An FDA-Approved THC Treatment

PrestoDoctor

Dronabinol, commonly known by its brand name Marinol, is an FDA-approved synthetic form of delta-9-tetrahydrocannabinol (THC) the primary psychoactive component found in cannabis. Used in medical settings, Dronabinol offers relief for patients struggling with chemotherapy-induced nausea, vomiting, and appetite loss associated with HIV/AIDS.

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.

article thumbnail

Clinical Trial: Cannabis Inhalation Associated with Clinical in Patients with Ulcerative Colitis

NORML

“This study demonstrates that treatment with THC-rich cannabis in patients with mild to moderate UC is associated with clinical improvement.". The post Clinical Trial: Cannabis Inhalation Associated with Clinical in Patients with Ulcerative Colitis appeared first on NORML.